Abstract
This article comments on the research by Zhang et al on the role of advanced heart failure and transplant teams in extracorporeal membrane oxygenation (ECMO) management. The study by Zhang et al indicates that direct advanced heart failure and transplant involvement improves survival in ECMO patients, especially those on veno-arterial ECMO. However, the optimal approach varies due to multiple factors. This article discusses the clinical implications, research design limitations, and future directions to enhance ECMO care.